Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HIVAC-FOUND: HIV-1 Vaccine Phase 1
NCT05772286Phase 1Active, not recruiting
- Sponsor
- Fundació Clínic per a la Recerca Biomèdica
- Start
- Jul 2023
- Primary completion
- Jun 2025
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of 763SIP8/MPLA-5 vaccine in human immunodeficiency virus infection (HIV), sponsored by Fundació Clínic per a la Recerca Biomèdica. Primary endpoints: Proportion of volunteers with a >= grade 3 solicited adverse (local or systemic), Proportion of volunteers with >= grade 3 and/or vaccine related unsolicited adverse events and 1 more. Started Jul 2023; status: active, not recruiting.
02
Drugs
763SIP8/MPLA-5 vaccine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT05772286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05772286.